Cutler Group LP Senseonics Holdings, Inc. Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$0.48 - $0.7 $40 - $59	85 Added 3.4%	2,582 $1,000
Q3 2023 Nov 07, 2023	BUY	$0.5 - $1.05 $73 - $153	146 Added 6.21%	2,497 $1,000
Q2 2023 Jul 18, 2023	SELL	$0.55 - $0.89 $1,760 - $2,848	-3,200 Reduced 57.65%	2,351 $1,000
Q1 2023 May 01, 2023	SELL	$0.68 - $1.25 $286 - $527	-422 Reduced 7.07%	5,551 $3,000
Q4 2022 Feb 07, 2023	SELL	$0.96 - $1.34 $18,887 - $26,363	-19,674 Reduced 76.71%	5,973 $6,000
Q3 2022 Oct 25, 2022	BUY	$1.02 - $2.23 $23,598 - $51,593	23,136 Added 921.39%	25,647 $33,000
Q2 2022 Aug 04, 2022	SELL	$0.94 - $1.94 $27,959 - $57,703	-29,744 Reduced 92.22%	2,511 $2,000
Q1 2022 Apr 14, 2022	BUY	$1.54 - $3.71 $8,941 - $21,540	5,806 Added 21.95%	32,255 $63,000
Q4 2021 Jan 18, 2022	SELL	$2.58 - $3.91 $163,252 - $247,409	-63,276 Reduced 70.52%	26,449 $70,000
Q3 2021 Oct 26, 2021	SELL	$2.77 - $4.05 $56,613 - $82,773	-20,438 Reduced 18.55%	89,725 $304,000
Q2 2021 Jul 19, 2021	SELL	$1.71 - $4.14 $20,791 - $50,338	-12,159 Reduced 9.94%	110,163 $423,000
Q1 2021 Apr 26, 2021	BUY	$0.85 - $5.27 $103,973 - $644,636	122,322 New	122,322 $322,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.